Oncotelic Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Oncotelic Therapeutics, Inc. (OTLC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $0.46 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2025-04-15
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2022-03-31 was $11.88.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2020-03-31 was $2.79.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2015-03-31 was $3.28.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2013-03-31 was $13.95.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was $0.46, a 96.13% decline from fiscal 2022.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2022 was $11.88, a 40.00% decline from fiscal 2021.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2021 was $19.80, a 2728.57% increase from fiscal 2020.
- Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2020 was $0.70, a 12.90% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.46 10-K · filed 2025-04-15 | |||
| 2023-09-30 | $0.46 10-Q · filed 2024-11-19 | |||
| 2023-06-30 | $0.46 10-Q · filed 2024-08-14 | |||
| 2022-12-31 | $11.88 10-K · filed 2024-04-12 | |||
| 2022-09-30 | $11.88 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | $11.88 10-Q · filed 2023-08-18 | |||
| 2022-03-31 | $11.88 10-Q · filed 2023-05-22 | |||
| 2021-12-31 | $19.80 10-K/A · filed 2023-04-20 | |||
| 2020-12-31 | $0.70 10-K · filed 2022-04-15 | |||
| 2020-09-30 | $2.72 10-Q · filed 2020-11-16 | |||
| 2020-06-30 | $2.79 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | $2.79 10-Q · filed 2020-06-29 | |||
| 2019-12-31 | $0.62 10-K · filed 2021-04-15 | |||
| 2019-09-30 | $0.62 10-Q · filed 2019-11-19 | |||
| 2019-06-30 | $0.41 10-Q · filed 2019-08-19 | |||
| 2015-03-31 | $3.28 10-Q · filed 2015-05-07 | |||
| 2014-12-31 | $33.40 10-K · filed 2015-03-30 | |||
| 2014-09-30 | $33.40 10-Q · filed 2014-11-13 | |||
| 2014-06-30 | $4.45 10-Q · filed 2014-08-08 | |||
| 2013-12-31 | $14.38 10-K · filed 2015-03-30 | |||
| 2013-09-30 | $16.48 10-Q · filed 2013-11-13 | |||
| 2013-06-30 | $17.66 10-Q/A · filed 2013-10-18 | |||
| 2013-03-31 | $13.95 10-Q · filed 2013-05-09 | |||
| 2012-12-31 | $66.21 10-K · filed 2015-03-30 | |||
| 2012-09-30 | $6.01 10-Q · filed 2012-11-09 | |||
| 2012-06-30 | $7.35 10-Q · filed 2012-08-13 | |||
| 2011-12-31 | $304.52 10-K · filed 2014-03-20 | |||
| 2010-12-31 | $810.99 10-K · filed 2013-03-15 |